Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OXALIPLATIN vs OXITRIPTAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OXALIPLATIN vs OXITRIPTAN: Safety Overview

Metric OXALIPLATIN OXITRIPTAN
Total FAERS Reports 56,406 100
Deaths Reported 6,501 5
Death Rate 11.5% 5.0%
Hospitalizations 21,980 34
Average Patient Age 61.5 yrs 52.2 yrs
% Female Patients 42.1% 58.6%
FDA Approval Date Apr 28, 2011 N/A
Manufacturer Camber Pharmaceuticals, Inc. Energique, Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued N/A